AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
10min chapter
Art Of The Pivot with Elevation Oncology's Joe Ferra
Business Of Biotech
Transitioning to ADC Programs in the Biotech Industry
This chapter explores the decision to shift from a monoclonal antibody to an ADC program, discussing the growth and potential of ADCs in targeting cancer cells with selectivity. It also highlights Elevation Oncology's approach to differentiation in a crowded landscape and their emphasis on serving all stakeholders for success.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode